These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22791280)

  • 1. Insulin: an emerging treatment for Alzheimer's disease dementia?
    Morris JK; Burns JM
    Curr Neurol Neurosci Rep; 2012 Oct; 12(5):520-7. PubMed ID: 22791280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.
    De Sousa RAL; Harmer AR; Freitas DA; Mendonça VA; Lacerda ACR; Leite HR
    Mol Biol Rep; 2020 Aug; 47(8):6347-6356. PubMed ID: 32740795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer's Disease.
    Rhea EM; Leclerc M; Yassine HN; Capuano AW; Tong H; Petyuk VA; Macauley SL; Fioramonti X; Carmichael O; Calon F; Arvanitakis Z
    Aging Dis; 2024 Aug; 15(4):1688-1725. PubMed ID: 37611907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and insulin resistance: translating basic science into clinical applications.
    De Felice FG
    J Clin Invest; 2013 Feb; 123(2):531-9. PubMed ID: 23485579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rationale for Insulin Therapy in Alzheimer's Disease.
    Ribarič S
    Molecules; 2016 May; 21(6):. PubMed ID: 27240327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
    Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
    Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.
    Bhattamisra SK; Shin LY; Saad HIBM; Rao V; Candasamy M; Pandey M; Choudhury H
    CNS Neurol Disord Drug Targets; 2020; 19(3):174-183. PubMed ID: 32418534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
    Mittal K; Katare DP
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics.
    Kuljiš RO; Salković-Petrišić M
    J Alzheimers Dis; 2011; 25(1):29-41. PubMed ID: 21335659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Insulin Resistance in the Alzheimer's Disease Progression.
    Nguyen TT; Ta QTH; Nguyen TTD; Le TT; Vo VG
    Neurochem Res; 2020 Jul; 45(7):1481-1491. PubMed ID: 32314178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.
    Duarte AI; Candeias E; Correia SC; Santos RX; Carvalho C; Cardoso S; Plácido A; Santos MS; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2013 Apr; 1832(4):527-41. PubMed ID: 23314196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.
    Chen Y; Zhang J; Zhang B; Gong CX
    Curr Top Med Chem; 2016; 16(5):485-92. PubMed ID: 26268336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.
    Velazquez R; Tran A; Ishimwe E; Denner L; Dave N; Oddo S; Dineley KT
    Neurobiol Aging; 2017 Oct; 58():1-13. PubMed ID: 28688899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin mediated novel therapies for the treatment of Alzheimer's disease.
    Dubey SK; Lakshmi KK; Krishna KV; Agrawal M; Singhvi G; Saha RN; Saraf S; Saraf S; Shukla R; Alexander A
    Life Sci; 2020 May; 249():117540. PubMed ID: 32165212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes-Mediated Alzheimer's Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin.
    Khan MS; Ikram M; Park TJ; Kim MO
    Oxid Med Cell Longev; 2021; 2021():4051207. PubMed ID: 33728019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    Nasoohi S; Parveen K; Ishrat T
    J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sugar diets, type 2 diabetes and Alzheimer's disease.
    Moreira PI
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):440-5. PubMed ID: 23657152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.